Inspire Veterinary Partners, Inc.
IVP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.03 | -0.05 | 0.01 | 0.01 |
| FCF Yield | -22.22% | -8.94% | -14.68% | -11.42% |
| EV / EBITDA | -11.95 | -11.91 | -13.91 | -8.00 |
| Quality | ||||
| ROIC | -10.86% | -14.59% | -11.00% | -8.56% |
| Gross Margin | 37.93% | 43.15% | 19.63% | 16.10% |
| Cash Conversion Ratio | 0.51 | 0.30 | 0.57 | 0.17 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.07% | 0.93% | 6.62% | 19.05% |
| Free Cash Flow Growth | -45.59% | 34.69% | -96.60% | 88.80% |
| Safety | ||||
| Net Debt / EBITDA | -8.31 | -7.50 | -8.16 | -5.75 |
| Interest Coverage | -3.52 | -6.24 | -4.92 | -5.17 |
| Efficiency | ||||
| Inventory Turnover | 5.38 | 5.11 | 6.16 | 5.39 |
| Cash Conversion Cycle | -39.80 | -47.82 | -39.74 | -46.14 |